Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma
Abstract The genomic instability (GI) /homologous recombination deficiency (HRD) score, calculated as the sum of the events of loss of heterozygosity (LOH), large-scale state transition (LST) and telomere allele imbalance (TAI), is used to guide the choice of treatment in several cancers, but its re...
Main Authors: | Juan Feng, Yang Lan, Feng Liu, Ye Yuan, Jia Ge, Sen Wei, Hu Luo, Jianjun Li, Tao Luo, Xiuwu Bian |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-023-00465-x |
Similar Items
-
Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
by: He Li, et al.
Published: (2023-04-01) -
The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs
by: Weiguo Gu, et al.
Published: (2024-02-01) -
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
by: Hao Sun, et al.
Published: (2020-10-01) -
Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy
by: Chih‐Hsun Wu, et al.
Published: (2019-10-01) -
A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations
by: Lei Niu, et al.
Published: (2023-02-01)